期刊文献+

PAC-1在人肝微粒体中的代谢产物分析 被引量:3

Identification of procaspase activating compound 1 metabolites in human liver microsomes
下载PDF
导出
摘要 目的初步阐明procaspase activating compound 1(PAC-1)在人肝微粒中的代谢情况。方法在一定的人肝微粒体浓度中加入药物,温孵后,采用液相色谱-飞行时间质谱法对孵化体系中的代谢产物进行分析。在正离子模式下,采用全扫描方式对代谢物进行检测。结果在人肝微粒体孵化体系中,除原型外共检测到4个代谢产物,代谢物的结构为脱苄基PAC-1和羟基化PAC-1。结论PAC-1在人肝微粒体系中的代谢途径为脱苄基化和羟基化。本研究结果对于进一步了解PAC-1在人体中的代谢和结构修饰具有重要的意义。 Objective To elucidate the metabolic pathway of procaspase activating compound 1(PAC-1)in human liver microsomes.Methods In this study,a liquid chromatography-time of flight mass spectrometric method was developed and applied to characterize the metabolites of PAC-1 after incubation with human liver microsomes.The analysis was performed under positive ion model with full scan method.Results Besides PAC-1,four metabolites were detected and the structures were proposed.Based on metabolite analysis,several PAC-1 metabolic pathways in human liver microsomes were proposed.Conclusions The result provides important information for the drug metabolism and structural modification research of PAC-1.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2010年第1期56-59,80,共5页 Journal of Shenyang Pharmaceutical University
关键词 procaspase ACTIVATING compound1 飞行时间质谱 代谢产物 procaspase activating compound 1 TOF MS metabolite
  • 相关文献

参考文献6

  • 1PUTT K S,CHEN G W,PEARSON J M,et al. Smallmolecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy [ J ]. Nat Chem Biol, 2006,2(10) :543 - 550.
  • 2DENAULT J B, DRAG M, SALVESEN G S, et al.Small molecules not direct activators of caspases [J]. Nat Chem Biol,2007,3(9) :519.
  • 3PORTER A G. Flipping the safety catch of procaspase- 3[J]. Nat Chem Biol,2006,2(10) :509 -510.
  • 4KOVAEIE P. Does structural commonality of metal complex formation by PAC-1 ( anticancer), DHBNH (antit-IIV) ,AHL(autoinducer) ,and UCS1025A( anticancer) denote mechanistic similarity Signal Transduction and Medical Aspects[J]. J Recept Signal Transduct Res ,2008,28 (3) : 141 - 152.
  • 5FANG Li-Na, CHEN Xiao-hui, SONG Zhen, et al. Development of a high performance liquid chromatography method for quantification of PAC-1 in rat plasma [ J]. Journal of Pharmaceutical and Biomedical Analysis,2008,49(2) :447 -450.
  • 6REN Lei, BI Kai-shun, GONG Ping, et al. Characterization of the in vivo and in vitro metabolic profile of PAC-1 using liquid chromatography-mass spectrometry [ J ]. J Chromatogr B Biomed Appl, 2008, 876 ( 1 ) : 47 - 53.

同被引文献35

  • 1陈怀侠,杜鹏,韩凤梅,陈勇.液相色谱-串联质谱法鉴定大鼠血浆中的东莨菪碱及其代谢物[J].分析化学,2006,34(6):851-854. 被引量:7
  • 2王素军,张志伟,赵艳红,张振清,谢海棠,阮金秀.建立大鼠原位肠-肝灌流模型评价绿原酸的代谢[J].中国临床药理学与治疗学,2006,11(12):1340-1344. 被引量:18
  • 3Danny C Hsu, Howard S Roth, Diana C West, et al. Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC- 1 ) [ J]. ACS Comb Sci,2012, 14:44.
  • 4Putt K S, Chert G W, Pearson J M, et al. Small- molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy [ J ]. Nat Chem Biol, 2006, 2:543.
  • 5Quinn P Peterson, Danny C Hsu, Chris J, et al. Novotny discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound [ J ]. Cancer Res, 2010, 70(18) :7232.
  • 6Pamela W Lucas, Joanna M Schmit, Quinn P Peterson, et al. Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1 , a preferential small molecule activator of procaspase-3, in healthy dogs [ J ]. Invest New Drugs, 2011, 29(5) :901.
  • 7Boldingh Debernard K A, Aziz G, Gjesvik A T, et al. Cell death induced by novel procaspase-3 activators can be reduced by growth factors [ J ]. Biochem Biophys Res Commun, 2011,413(2) :364.
  • 8Peterson Q P, Goode D R, West D C, et al. PAC-1 activates procaspase-3 in vitro through relief of zinc- mediated inhibition[ J]. Mol Biol,2009, 388 : 144.
  • 9Peterson Q P, Hsu D C, Goode D R, et al. Procaspase- 3 activation as an anticance rstrategy: Structure activity relationship of procaspase-activating compound 1 ( PAC- 1 ) and its cellular co-localization with caspase-3 [ J ]. Med Chem,2009, 52:5721.
  • 10KOVAEIE P. Does structural commonality of metal complex formation by PAC-1 ( anticancer ) , dhbnh ( anti-hiv ), ahl ( autoinducer ), and ucs1025a ( anticancer ) denote mechanistic similarity signal transduction and medical aspects [ J]. J Recept Signal Transduct Res, 2008, 28 (3) : 141.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部